Journal September 26, 2026 6 min read

What does the research say about insulin sensitivity?

A research-supply overview of insulin sensitivity as studied in PCOS, pre-diabetes, T2DM, obesity, MASLD, and aging models, with the specific mechanisms, tissues, and populations reported in the cited evidence.

peptides-pro Editorial

Insulin sensitivity is the term used in the cited literature for the responsiveness of target tissues to insulin-mediated glucose disposal; its inverse, insulin resistance (IR), is described in the same sources as a state in which higher insulin concentrations are required to achieve a given metabolic effect. The evidence block does not supply a sequence, formula, or molecular weight for insulin sensitivity, because it is a physiological parameter rather than a single molecular entity. The identifiers that appear in the evidence are study-level: ClinicalTrials.gov records NCT07811011, NCT07752225, and NCT07791394, and the PubMed/Europe PMC records listed under Sources.

The work summarised here centres on the insulin receptor and its downstream glucose-handling pathway, with additional input from incretin signalling through dipeptidyl peptidase-4 (DPP-4), from neuropeptides involved in glucose homeostasis, and from mitochondrial and inflammatory pathways that modify insulin action in peripheral tissues.

Research Studies

Vildagliptin and insulin sensitivity in polycystic ovary syndrome

A registered trial compares vildagliptin with metformin in patients with polycystic ovary syndrome (PCOS) [1]. The record describes PCOS as an endocrine and metabolic disorder characterised by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology, with insulin resistance playing a central role in its pathophysiology. It states that hyperinsulinaemia can enhance ovarian androgen production and reduce hepatic sex hormone-binding globulin synthesis, thereby aggravating hyperandrogenism and reproductive abnormalities. Vildagliptin is described as a DPP-4 inhibitor that enhances endogenous incretin activity and may improve insulin sensitivity and glucose homeostasis, with emerging evidence that DPP-4 inhibition may also influence body weight, androgen excess, and inflammation [1].

Avocado consumption and brain insulin sensitivity in pre-diabetic adults

A randomised crossover intervention study is assessing the effect of 12 weeks of daily avocado consumption in pre-diabetic individuals with overweight or obesity [2]. The primary aim is to assess cerebral blood flow and markers of cardio- and vascular health in the periphery and the brain. The secondary objective is to assess effects on brain insulin sensitivity after intranasal insulin delivery, vascular function, markers of metabolic health, cognition, and psychological well-being. The planned sample is 34 men and women aged 40–75 years [2].

Spexin and galanin in type 2 diabetes mellitus

A systematic review and meta-analysis synthesised evidence on circulating spexin and galanin concentrations in patients with type 2 diabetes mellitus (T2DM) [3]. Spexin and galanin are described as neuropeptides involved in glucose homeostasis, insulin sensitivity, appetite, and energy metabolism. PubMed/MEDLINE, Scopus, and Web of Science were searched from inception to March 22, 2026, and observational studies reporting circulating spexin and/or galanin levels in adults with T2DM and non-diabetic controls were included; random-effects meta-analyses calculated pooled standardised mean differences with 95% confidence intervals [3].

Estimated glucose disposal rate and self-reported endometrial cancer

A cross-sectional study from NHANES 1999–2018 evaluated whether the estimated glucose disposal rate (eGDR), described as a feasible non-invasive IR metric, is associated with self-reported endometrial cancer [4]. The analytical sample consisted of 31,666 female respondents, including 248 endometrial cancer cases and 31,418 cancer-free comparators, with 1:1 propensity score matching to control for baseline imbalances. The eGDR was significantly lower in the endometrial cancer group (6.84 ± 2.76) than in the control group (7.51 ± 2.66) (P = 0.004), and an adjusted odds ratio was reported after controlling for confounding variables [4].

Group	eGDR (mean ± SD)	P value
Self-reported endometrial cancer (n = 248)	6.84 ± 2.76	0.004
Cancer-free comparators (n = 31,418)	7.51 ± 2.66

Sulforaphane and broccoli-derived preparations in obesity-related metabolic dysfunction

A narrative review evaluated sulforaphane, a bioactive isothiocyanate derived primarily from broccoli and other cruciferous vegetables, in obesity and obesity-related metabolic dysfunction [5]. The review frames obesity as characterised by adipose tissue dysfunction, insulin resistance, chronic low-grade inflammation, oxidative stress, mitochondrial dysfunction, and increased cardiometabolic risk, and notes that limitations related to cost, adverse effects, and long-term adherence have stimulated interest in complementary nutritional approaches. The review is described as critically evaluating mechanistic insights, preclinical evidence, and clinical perspectives [5].

MitoQ and SS-31 (elamipretide) in aged female mice with MASLD

This study is animal-only. Aged female C57BL/6 mice (12–14 months) were fed a high-fat, high-fructose diet for 16 weeks to induce metabolic dysfunction-associated steatotic liver disease (MASLD), then randomised into four groups: control diet, MASLD, MASLD + MitoQ (25 mg/kg/day), and a further group [6]. The study compares the mitochondria-targeted agents MitoQ and SS-31 for their effects on mitochondrial function, oxidative stress, apoptosis, and inflammation. The rationale given is that early mitochondrial dysfunction drives lipid imbalance, inflammation, and fibrosis, and that approved pharmacological treatments are lacking [6].

Estrogen and the response of glycaemic control to exercise training

A registered study addresses whether estrogen blunts the effects of exercise training on glycaemic control [7]. The record states that previous research has found males and females respond differently to exercise training, particularly with respect to improvements in blood sugar control and immune system health, and that females appear to benefit less from exercise than males. The investigators propose that this difference might be due to estrogen, described as a hormone that helps regulate blood sugar in non-exercising conditions and reduce inflammation [7].

Sleep, muscle metabolism, and Alzheimer's disease vulnerability

A review advances a sleep–muscle–brain framework in which sarcopenia, sarcopenic obesity, and insulin resistance are conceptualised as modifiable muscle-metabolic conditions that may bias sleep continuity and shape the biological impact of sleep disruption [8]. The review notes that reduced slow-wave sleep, increased fragmentation, and circadian instability may facilitate amyloid-β accumulation, tau propagation, neuroinflammation, oxidative stress, and impaired glymphatic clearance, and argues that physiological factors predisposing older adults to unstable sleep remain insufficiently integrated into models of brain aging [8].

Microbial and central pathways reported in the reference-only literature

Additional papers in the evidence block report findings relevant to insulin sensitivity without being the page's content. One reports that the probiotic Bifidobacterium pseudocatenulatum converts hesperidin to bioactive hesperetin and improves metabolic dysfunction in aging mice, noting that hesperidin depends on gut microbial biotransformation to yield its active aglycone and that hesperetin activates CDGSH iron-sulfur domain proteins [9]. Another reports that autophagy in hypothalamic POMC and AgRP neurons exerts divergent metabolic effects within the arcuate nucleus, in a context where hypothalamic nutrient sensing, leptin responsiveness, and intracellular quality control are intertwined [10]. A cross-sectional study compared bone mineral density, body composition, sex hormone levels, and insulin sensitivity in 51 women with Polyendocrine Metabolic Ovarian Syndrome against women without the syndrome [11]. A further paper reports that blocking PD-L2 prevents senescent cell accumulation and age-related dysfunction, in a context where senescent cells contribute to metabolic dysfunction and impaired fitness [12].

If you are reading this for personal health reasons

The materials described here are sold for laboratory research only, and we do not provide dosing or medical guidance. Nothing on this page is a recommendation for any person to use any compound. Anyone considering a compound for themselves should speak to a licensed clinician.